Doron Gothelf

4.8k total citations
39 papers, 2.1k citations indexed

About

Doron Gothelf is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Doron Gothelf has authored 39 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 22 papers in Epidemiology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Doron Gothelf's work include Congenital heart defects research (38 papers), Congenital Heart Disease Studies (22 papers) and Coronary Artery Anomalies (17 papers). Doron Gothelf is often cited by papers focused on Congenital heart defects research (38 papers), Congenital Heart Disease Studies (22 papers) and Coronary Artery Anomalies (17 papers). Doron Gothelf collaborates with scholars based in Israel, United States and Switzerland. Doron Gothelf's co-authors include Abraham Weizman, Amos Frisch, Allan L. Reiss, Stéphan Eliez, Stéphan Eliez, Tamar Green, Marie Schaer, Hower Kwon, Tracy Thompson and Carl Feinstein and has published in prestigious journals such as Nature Neuroscience, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Doron Gothelf

39 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doron Gothelf Israel 24 1.5k 801 675 608 503 39 2.1k
Edward Moss United States 17 996 0.7× 388 0.5× 814 1.2× 668 1.1× 322 0.6× 26 1.7k
Omar Khwaja United States 24 922 0.6× 619 0.8× 158 0.2× 326 0.5× 361 0.7× 55 2.5k
Tamar Green United States 20 632 0.4× 382 0.5× 223 0.3× 226 0.4× 286 0.6× 51 1.2k
Kate Baker United Kingdom 21 704 0.5× 545 0.7× 160 0.2× 145 0.2× 316 0.6× 45 1.4k
Jeannie Visootsak United States 26 1.2k 0.8× 2.0k 2.4× 81 0.1× 62 0.1× 1.1k 2.2× 54 2.7k
Myriam Srour Canada 20 703 0.5× 653 0.8× 60 0.1× 99 0.2× 197 0.4× 88 1.9k
Carole Samango‐Sprouse United States 24 846 0.6× 1.2k 1.5× 141 0.2× 45 0.1× 322 0.6× 71 2.0k
Maria T. Acosta United States 20 386 0.3× 253 0.3× 174 0.3× 53 0.1× 333 0.7× 63 1.3k
Carolyn Ellaway Australia 29 959 0.6× 1.8k 2.3× 102 0.2× 40 0.1× 1.1k 2.1× 81 2.6k
Lorenzo Sinibaldi Italy 20 447 0.3× 509 0.6× 56 0.1× 69 0.1× 414 0.8× 46 1.5k

Countries citing papers authored by Doron Gothelf

Since Specialization
Citations

This map shows the geographic impact of Doron Gothelf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doron Gothelf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doron Gothelf more than expected).

Fields of papers citing papers by Doron Gothelf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doron Gothelf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doron Gothelf. The network helps show where Doron Gothelf may publish in the future.

Co-authorship network of co-authors of Doron Gothelf

This figure shows the co-authorship network connecting the top 25 collaborators of Doron Gothelf. A scholar is included among the top collaborators of Doron Gothelf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doron Gothelf. Doron Gothelf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michaelovsky, Elena, Miri Carmel, Doron Gothelf, & Abraham Weizman. (2024). Lymphoblast transcriptome analysis in 22q11.2 deletion syndrome individuals with schizophrenia-spectrum disorder. The World Journal of Biological Psychiatry. 25(4). 242–254. 1 indexed citations
2.
Levy‐Shraga, Yael, Doron Gothelf, Uriel Katz, et al.. (2017). Growth characteristics and endocrine abnormalities in 22q11.2 deletion syndrome. American Journal of Medical Genetics Part A. 173(5). 1301–1308. 12 indexed citations
3.
Yi, James, Ronnie Weinberger, Tyler M. Moore, et al.. (2016). Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts. Brain and Cognition. 106. 33–41. 17 indexed citations
4.
Nachmani, Ariela, et al.. (2016). Association between prematurity and the evolution of psychotic disorders in 22q11.2 deletion syndrome. Journal of Neural Transmission. 123(12). 1491–1497. 10 indexed citations
5.
Gothelf, Doron, Amos Frisch, Abraham Weizman, et al.. (2015). Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome. Pediatric Research. 77(4). 579–585. 20 indexed citations
6.
Weisman, Omri, Ruth Feldman, Miri Keren, et al.. (2015). Mother–Child Interaction as a Window to a Unique Social Phenotype in 22q11.2 Deletion Syndrome and in Williams Syndrome. Journal of Autism and Developmental Disorders. 45(8). 2567–2577. 23 indexed citations
7.
Carmel, Miri, Omer Zarchi, Elena Michaelovsky, et al.. (2014). Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects. Journal of Psychiatric Research. 56. 28–35. 24 indexed citations
8.
Zarchi, Omer, Adele Diamond, Ronnie Weinberger, et al.. (2013). A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: Velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes. European Psychiatry. 29(4). 203–210. 23 indexed citations
9.
Zarchi, Omer, Miri Carmel, J. Attias, et al.. (2013). Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes. Journal of Psychiatric Research. 47(11). 1623–1629. 31 indexed citations
10.
Gothelf, Doron, Amanda J. Law, Amos Frisch, et al.. (2013). Biological Effects of COMT Haplotypes and Psychosis Risk in 22q11.2 Deletion Syndrome. Biological Psychiatry. 75(5). 406–413. 48 indexed citations
11.
12.
Michaelovsky, Elena, Amos Frisch, Miri Carmel, et al.. (2012). Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Medical Genetics. 13(1). 122–122. 71 indexed citations
13.
Green, Tamar, Doron Gothelf, Bronwyn Glaser, et al.. (2009). Psychiatric Disorders and Intellectual Functioning Throughout Development in Velocardiofacial (22q11.2 Deletion) Syndrome. Journal of the American Academy of Child & Adolescent Psychiatry. 48(11). 1060–1068. 222 indexed citations
14.
Gothelf, Doron, Amos Frisch, Elena Michaelovsky, Abraham Weizman, & Robert J. Shprintzen. (2009). Velocardiofacial Syndrome. Journal of Mental Health Research in Intellectual Disabilities. 2(2). 149–167. 48 indexed citations
15.
Gothelf, Doron, Marie Schaer, & Stéphan Eliez. (2008). Genes, brain development and psychiatric phenotypes in velo‐cardio‐facial syndrome. PubMed. 14(1). 59–68. 101 indexed citations
16.
Gothelf, Doron, Carl Feinstein, Tracy Thompson, et al.. (2007). Risk Factors for the Emergence of Psychotic Disorders in Adolescents With 22q11.2 Deletion Syndrome. American Journal of Psychiatry. 164(4). 663–669. 169 indexed citations
17.
Gothelf, Doron, Ayala Aviram‐Goldring, Merav Burg, et al.. (2007). Cognition, psychosocial adjustment and coping in familial cases of velocardiofacial syndrome. Journal of Neural Transmission. 114(11). 1495–1501. 6 indexed citations
18.
Gothelf, Doron, et al.. (2005). The contribution of novel brain imaging techniques to understanding the neurobiology of mental retardation and developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews. 11(4). 331–339. 16 indexed citations
19.
Gothelf, Doron, Merav Burg, Michael Berant, et al.. (2003). Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 126B(1). 116–121. 76 indexed citations
20.
Gothelf, Doron, Amos Frisch, Hanan Munitz, et al.. (1999). Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophrenia Research. 35(2). 105–112. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Moss Breakdown of academic impact, for papers by Omar Khwaja Breakdown of academic impact, for papers by Tamar Green Breakdown of academic impact, for papers by Kate Baker Breakdown of academic impact, for papers by Jeannie Visootsak Breakdown of academic impact, for papers by Myriam Srour Breakdown of academic impact, for papers by Carole Samango‐Sprouse Breakdown of academic impact, for papers by Maria T. Acosta Breakdown of academic impact, for papers by Carolyn Ellaway Breakdown of academic impact, for papers by Lorenzo Sinibaldi
Rankless by CCL
2026